Can reperfusion injury of the liver be prevented? Trying to improve on a good thing.
- 1 December 2001
- journal article
- research article
- Published by Wiley in Pediatric Transplantation
- Vol. 5 (6) , 390-3
- https://doi.org/10.1034/j.1399-3046.2001.00047.x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Effect of treatment with prostaglandin E1 and N‐acetylcysteine on pediatric liver transplant recipients: A single‐center studyPediatric Transplantation, 2001
- Ischemia impairs liver regeneration after major tissue loss in rodents: Protective effects of interleukin-6Hepatology, 1999
- Age-Related Changes on Parameters of Experimentally-Induced Liver Injury and RegenerationToxicology and Applied Pharmacology, 1999
- PROSTAGLANDIN E1 ANALOGS DO NOT IMPROVE RENAL FUNCTION AMONG EITHER TRANSPLANT OR NONTRANSPLANT PATIENTSTransplantation, 1998
- Sinusoidal endothelial cell injury during hepatic preservation and reperfusionHepatology, 1998
- Prostaglandin E1 administration following orthotopic liver transplantation: A randomized prospective multicenter trialGastroenterology, 1996
- ENISOPROST IN LIVER TRANSPLANTATIONTransplantation, 1995
- Improvement by Acetylcysteine of Hemodynamics and Oxygen Transport in Fulminant Hepatic FailureNew England Journal of Medicine, 1991
- TREATMENT OF PRIMARY LIVER GRAFT NONFUNCTION WITH PROSTAGLANDIN E1Transplantation, 1989
- Efficacy of Oral N-Acetylcysteine in the Treatment of Acetaminophen OverdoseNew England Journal of Medicine, 1988